EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.541
https://www.valueinhealthjournal.com/article/S1098-3015(23)00641-1/fulltext
Section Title :
Section Order :
10024
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00641-1&doi=10.1016/j.jval.2023.03.541